Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: National Cancer Institute (NCI)
Condition: Recurrent Non-small Cell Lung Cancer
NCT00245063
AZD2171 in Treating Patients With Recurrent Small Cell Lung Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.